Given the role of HLTF in the control of the error-free branch of damage tolerance, it is tempting to speculate that it could be beneficial for tumor cells to inactivate HLTF in order to channel the PRR pathway toward the more mutagenic TLS bypass, thus allowing the malignant cells to accumulate more mutations. Here, HLTF is linked to neoplasm.